/C O R R E C T I O N -- Seraphina Therapeutics/

PR Newswire
Tuesday, August 12, 2025 at 3:08pm UTC

/C O R R E C T I O N -- Seraphina Therapeutics/

PR Newswire

In the news release, Seraphina Therapeutics Ranks No. 177 on the 2025 Inc. 5000 List of America's Fastest-Growing Private Companies, issued Aug. 12, 2025 by Seraphina Therapeutics over PR Newswire, we are advised by a representative of the company that the headline should instead read "Seraphina Therapeutics Ranks No. 117 on the 2025 Inc. 5000 List of America's Fastest-Growing Private Companies". The complete, corrected release follows:

Seraphina Therapeutics Ranks No. 117 on the 2025 Inc. 5000 List of America's Fastest-Growing Private Companies

With Three-Year Revenue Growth of 3,031% Percent, This Marks Seraphina's Debut on the List

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced that Seraphina Therapeutics is No.117 on the annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy's most dynamic segment—its independent, entrepreneurial businesses. Past honorees include companies such as Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle, and Patagonia.

"We are proud that fatty15, our groundbreaking and science-backed C15:0 longevity supplement, has catapulted Seraphina to be among the top 2% of fastest growing companies in America, furthering our global mission to meaningfully improve people's lives within months," says Dr. Eric Venn-Watson, Seraphina's Co-Founder and Co-CEO. "From helping Navy dolphins to improving global health - we couldn't have asked for a more fulfilling journey." Seraphina is led by Co-Founders Dr. Eric and Stephanie Venn-Watson, a husband-and-wife, physician-and-veterinarian military family duo of entrepreneurs.

This year's Inc. 5000 honorees have demonstrated exceptional growth while navigating economic uncertainty, inflationary pressure, and a fluctuating labor market. Among the top 500 companies on the list, the median three-year revenue growth rate reached 1,552 percent, and those companies have collectively added more than 48,678 jobs to the U.S. economy over the past three years.

For the full list, company profiles, and a searchable database by industry and location, visit: www.inc.com/inc5000.

"Making the Inc. 5000 is always a remarkable achievement, but earning a spot this year speaks volumes about a company's tenacity and clarity of vision," says Mike Hofman, editor-in-chief of Inc. "These businesses have thrived amid rising costs, shifting global dynamics, and constant change. They didn't just weather the storm—they grew through it, and their stories are a powerful reminder that the entrepreneurial spirit is the engine of the U.S. economy."

Inc. will celebrate the honorees at the 2025 Inc. 5000 Conference & Gala, taking place October 22–24 in Phoenix, and the top 500 will be listed in the Fall issue of Inc. magazine.

Since Seraphina's launch of fatty15 in January 2021, this first-of-its-kind longevity supplement has maintained a 95% monthly customer retention rate from enthusiastic customers and currently has over 100,000 active subscribers. Fatty15's robust direct-to-consumer performance, coupled with more recent expansions into the Amazon.com and healthcare provider channels, have led to Seraphina's 3,031% growth from 2021 to 2024 and its earned top-spot on Inc. 5000 as the 5th fastest growing Consumer Product company in America.

Methodology
Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons.

About Inc.: Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.

Media Contact
Fatty15 Press Office
Fatty15
1 619-407-9225
press@fatty15.com
https://www.fatty15.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/seraphina-therapeutics-ranks-no-177-on-the-2025-inc-5000-list-of-americas-fastest-growing-private-companies-302527045.html

SOURCE Seraphina Therapeutics